how to compound glp 1 versions of GLP-1 drugs for weight loss halted by FDA FDA says that the GLP-1
Description
Researchers at Valley Health System in New Jersey looked at the medical charts of 38 people with hormone receptor-positive breast cancer taking both hormonal therapy and weight loss drugs

2019;10:p

You get medical oversight from clinicians who specialize in weight management

"It is scary
This is still one of our largest remaining hurdles

Mounjaro was approved in 2022 for type 2 diabetes, while Zepbound was approved in 2023 specifically for chronic weight management
